- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
- Video and telephone consultations
Dr Toby Eyre is a consultant haematologist at Oxford University Hospitals NHS Foundation Trust, specialising in the management of lymphoid malignancies. He is considered a national expert in the management of patients with lymphoma and patients with chronic lymphocytic leukaemia.
Toby has completed an MD Doctorate Thesis in early phase trials and biomarker studies in aggressive lymphoid disease in 2017. He completed his haematology training in the Oxford deanery between 2010 and 2017.
Toby is an investigator on a number of national UK lymphoma and chronic lymphocytic leukaemia trials and has published 135 peer-review articles on areas of lymphoma and CLL and has presented regularly at national and international conferences. He is also a core member of the low grade lymphoma and elderly high grade lymphoma NCRI clinical studies group and a member of the BSCH writing group for follicular lymphoma, post-transplantation lymphoproliferative disorders, Richters transformation and CLL guidelines.
Toby has a strong interest in teaching and training and has completed a post-graduate Diploma in Medical Education.
Areas of interest
Lymphoma; CLL; Haematology; Chronic Lymphocytic Leukaemia; haemato-oncology, lymphoid malignancies; Hodgkins Lymphoma; Non-Hodgkins Lymphoma; Clinical trials; immunotherapy; chemotherapy
Information for healthcare professionals (Bupa patients only, last 12 months)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
GenesisCare, Oxford (5-50)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (1-5)